GLOBAL BIOBUSINESS FRONTIER
GLOBAL BIOBUSINESS FRONTIER

 Home > Company >History


To become a global scale biopharmaceutical company
 thru successfully meeting & overcoming challenges!!

2015


2015.07

Establishment of Kanzen


2015.10

Selection of microorganism producing  high-molecular weight hyaluronic acid

2016


2016.09

Entered joint-work agreement with SNU Industry-Academic Cooperation foundation about improvement of microorganisms producing high-molecular weight hyaluronic acid


2016.09

Certification of company-affiliated research institute


2016.11

Certification of venture company


2016.12

Signed with SNU Industry-Academic Cooperation foundation about Technology transfer/ownership transfer of candidates for the treatment of pruritus


2016.12

Signed MOU with Proteometech about  global marketing rights of TriCheck and technology  collaboration

2017


2017.01

Signed MOU with ProCell Terapeutics

for Commercialization of Macromolecule Intracellular Transduction Technology


2017.04

Signed with ELT science about service contract

/ Foot and mouth disease vaccine Stress reliever1


2017.05

Signed with SNU Industry-Academic Cooperation foundation about co-work/development of Botulinum toxin purification process


2017.05

Selected government task/ Animal medicine non-freezing antiseptic

( Participating organizations : Animal and Plant Quarantine Agency)